Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
65 hedge funds and large institutions have $379M invested in Amryt Pharma plc American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 4 closing their positions.
775% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 4
600% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 2
111% more capital invested
Capital invested by funds: $180M → $379M (+$199M)
91% more funds holding
Funds holding: 34 → 65 (+31)
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$36.8M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$33.9M |
| 3 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$30.1M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$14.6M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$10.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$485K |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$421K |
| 3 |
Renaissance Technologies
New York
|
-$270K |
| 4 |
CCM
Context Capital Management
Lajolla,
California
|
-$58.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$48.3K |
AMYT Hedge Fund Activity: Q3 2021 in Review
65 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q3 2021, worth a combined $379M — up 111% from $180M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new AMYT positions and 4 closed out — a net gain of 31 holders — while 14 added to existing stakes and 2 trimmed.
The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $36.8M. The largest seller was Tudor Investment Corp, exiting entirely with an estimated $485K sold.
- 65 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q3 2021, up from 34 in Q2 2021.
- Funds reported $379M of Amryt Pharma plc American Depositary Shares stock for Q3 2021, up 111% quarter-over-quarter.
- 35 funds opened new Amryt Pharma plc American Depositary Shares positions in Q3 2021 and 4 closed out, a net change of +31 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q3 2021 was Rubric Capital Management (New York), an estimated $36.8M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q3 2021 was Tudor Investment Corp, an estimated $485K sold.
Based on aggregated 13F filings for Q3 2021.